Cochrane · systematic review · CD003563
Dehumidifiers for chronic asthma
Singh, M, Jaiswal, N · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
AirwaysAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 7 · 100%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
MHRV compared to placebo for asthmatics with sensitivity to house dust mite
Population: asthmatics with sensitivity to house dust mite
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Change in Morning PEF after 12 months (% predicted) MHRV vs placebo | MD 13.59 | 1 study · 100 participants | Moderate Downgraded: imprecision |
Change in Evening PEF after 12 months (% predicted) MHRV vs placebo | MD 24.56 [8.97, 40.15] | 1 study · 100 participants | Moderate Downgraded: imprecision |
Change in FEV1 after 12 months (% predicted) MHRV vs placebo | MD 1.32 | 1 study · 100 participants | Moderate Downgraded: imprecision |
Quality of life SGRQ Scale from 0 to 100 (0 on the scale is better) MHRV vs placebo | no estimate extracted | 1 study · 100 participants | Moderate Downgraded: imprecision |
Exacerbations needing oral steroids MHRV vs placebo | OR 0.52 [0.22, 1.24] | 1 study · 100 participants | Moderate Downgraded: imprecision |
Exacerbations needing ED visit MHRV vs placebo | OR 1.84 [0.32, 10.52] | 1 study · 100 participants | Moderate Downgraded: imprecision |
Exacerbations needing hospitalisation MHRV vs placebo | OR 0.09 [0, 1.72] | 1 study · 100 participants | Moderate Downgraded: imprecision |